News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Crucell N.V. (CRXL) Announces European Protein Distribution Deal with Talecris Biotherapeutics



4/3/2007 10:31:39 AM

LEIDEN, NETHERLANDS -- (MARKET WIRE) -- April 03, 2007 -- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a long-term distribution deal with North Carolina-headquartered Talecris Biotherapeutics, GmBH.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES